Stay updated on Benralizumab for Severe Nasal Polyposis Clinical Trial
Sign up to get notified when there's something new on the Benralizumab for Severe Nasal Polyposis Clinical Trial page.

Latest updates to the Benralizumab for Severe Nasal Polyposis Clinical Trial page
- Check4 days agoChange DetectedThe record now presents details of AstraZeneca’s completed Phase 3 study of benralizumab for severe nasal polyposis, including study methods, participant criteria, outcome measures, and supporting documents.SummaryDifference100%

- Check11 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedA sitewide NIH announcement about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the page. The site revision label changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check39 days agoChange DetectedThe footer revision identifier changes from v3.7.0 to v3.7.1; the study record remains unavailable behind a 403 error.SummaryDifference0.2%

- Check52 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the full study record, with minimal HTML header text and a Home link.SummaryDifference19%

- Check59 days agoChange DetectedThe page revision label was updated from v3.6.6 to v3.7.0, indicating a new version of the page's implementation or documentation. This change reflects an update to the page's underlying resources rather than to user-facing content.SummaryDifference0.0%

- Check73 days agoChange DetectedThe page now shows Revision: v3.6.6, replacing the previous v3.6.5. This reflects a minor version update and does not change the study information presented.SummaryDifference0.0%

Stay in the know with updates to Benralizumab for Severe Nasal Polyposis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Benralizumab for Severe Nasal Polyposis Clinical Trial page.